Evidence map›Paper›PMID 29996204›Full record

Trial reportZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2018

[Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data].

L Wei, J Cheng, J Luo, Z P Li, J L Duan, J D Hou, M X Jia, Y Zhang, Q Huang, G J Xie and 14 more

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Antiviral treatment and prognosis in patients undergoing maintenance hemodialysis due to hepatitis C virus.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  2. Article
  3. Article
  4. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 2 countries.

L WeiPeking University People's Hospital, Beijing 100044, China.
J ChengBeijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
J LuoAbbVie Inc., North Chicago 60064, IL, USA.
Z P LiJiangsu Province Hospital, Nanjing 210029, China.
J L DuanBeijing You'an Hospital, Capital Medical University, Beijing 100069, China.
J D HouNan Fang Hospital, Guangzhou 510515, China.
M X JiaBeijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Y ZhangShenyang 6th People's Hospital, Shenyang 110006, China.
Q HuangXiangya Hospital Central South University, Changsha 410008, China.
G J XieRui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
D L WangPeking University First Hospital, Beijing 100034, China.
W YangUnion Hospital Tongji Mecical College, Huazhong University of Science and Technology, Wuhan 430022, China.
C Y ZhaoNanjing 2nd Hospital, Nanjing 210028, China.
G ZhaoThe 3rd Hospital of Hebei Medical University, Shijiazhuang 500000, China.
S M TangWest China School of Medicine, Chengdu 610041, China.
G Z LinThe 1st Hospital of Xi'an Jiaotong Univeersity, Xi'an 710065, China.
J J GongThe 2nd Hospital of Central South University, Changsha 410011, China.
Z L NiuThe 1st Hospital of Jilin University, Changchun 130021, China.
J F GaoThe 3rd Hospital, Sun Yay-sen Hospital, Guangzhou 510630, China.
Kopecky-Bromberg SarahAbbVie Inc., North Chicago 60064, IL, USA.
Fredrick LindaAbbVie Inc., North Chicago 60064, IL, USA.
Mobashery NiloufarAbbVie Inc., North Chicago 60064, IL, USA.
Ye WangAbbVie. China. Shanghai 200041, China.
Jiefei WangShanghai Public Health Clinical Center, Shanghai 201508, China.
AbbVie (United States) · USCentral South University · CNBeijing Ditan Hospital · CNBeijing Friendship Hospital · CNBeijing YouAn Hospital · CNHuazhong University of Science and Technology · CNJiangsu Province Hospital · CNPeking University · CNPeking University People's Hospital · CNRuijin Hospital · CNSecond Affiliated Hospital of Jilin University · CNShanghai Public Health Clinical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis C, Chronic2-NaphthylamineAdultAlanine TransaminaseAnilidesAntiviral AgentsAsian PeopleAspartate AminotransferasesBilirubinCarbamatesChinaCyclopropanesDouble-Blind MethodDrug Therapy, CombinationGenotypeHepacivirus2-NaphthylamineAlanine TransaminaseAnilidesAntiviral AgentsAspartate AminotransferasesBilirubinCarbamatesCyclopropanesdasabuvirInterferon-alphaLactams, MacrocyclicMacrocyclic CompoundsombitasvirparitaprevirProlineRibavirinRitonavirSulfonamidesUracilValineDirect-acting antiviral agentHepatitis C, chronicSafety

Identifiers

PMID29996204
PMCPMC12769254
OpenAlexW3025979317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.